Prevalence of extended spectrum beta lactamases in uropathogenic Escherichia coli and Klebsiella species in a Chennai suburban tertiary care hospital and its antibiogram pattern

Research Journal of Microbiology

Volumn 6, Issue 11, 2011, Pages 796-804

  Gururajan, Gayathri ^a   Kaliyaperumal, Kathireshan A ^b   Ramasamy, Balagurunathan ^c  

^a BHARATHIAR UNIVERSITY   (India)

^b VELS INSTITUTE OF SCIENCE   (India)

^c PERIYAR UNIVERSITY   (India)

Author keywords

lactams; Cefotaxime; Ceftazidime; Extended spectrum beta lactamases; Minimum inhibitory concentration; Multidrug resistance; Uropathogens

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; KLEBSIELLA;

EID: 80055096406     PISSN: 18164935     EISSN: None     Source Type: Journal    
DOI: 10.3923/jm.2011.796.804     Document Type: Article

References (32)

1. Aggarwal, R., U. Chaudhary and R. Sikka, 2009. Detection of extended spectrum β-lactamase production among uropathogens. J. Lab. Phys., 1: 7-10.
2. Akram, M., M. Shahid and A.U. Khan, 2007. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann. Clin. Microbiol. Antimicrob., 6: 4-4.
3. Al-Jasser, A.M., 2006. Extended-spectrum β-lactamases (ESBLs): A global problem. Kuwait Med. J., 38: 171-185.
4. Babypadmini, S. and B. Appalaraju, 2004. Extended-spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-prevalence and susceptibility pattern in a tertiary care hospital. Indian J. Med. Microbiol., 22: 172-174.
5. Bhowmick, B.K. and H. Rashid, 2004. Prevalence and antibiotic susceptibility of E. coli isolated from urinary tract infection (UTI) in Bangladesh. Pak. J. Biol. Sci., 7: 717-720.
6. Boucher, H.W., G.H. Talbot, J.S. Bradley, J.E. Edwards and D. Gilbert et al., 2009. Bad bugs, no drugs: No eskape! An update from the infectious diseases society of America. Clin. Infect. Dis., 48: 1-12.
7. Bradford, P.A., 2001. Extended spectrum beta-lactamases in the 21st century: Characterization, epidemiology and detection of this important resistance threat. Clin. Microbial. Rev., 14: 933-951.
8. CLSI, 2005. Performance standards for antimicrobial susceptibility testing. CLSI Approved Standards M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA. CDC. USA.
9. Fish, D.N., 2009. Urinary Tract Infections. In: Applied Therapeutics: The Clinical Use of Drugs, Kimble, M.A.K., L.Y. Young, W.A. Kradjan, J. Guglielmo, B.K. Alldredge, R.L. Corelli and B.R. Williams (Eds.). 9th Edn., Wolters Kluwer/Lippincott Williams and Wilkins, Philadelphia, USA.
10. Gupta, V., 2007. An update on newer β-lactamases. Indian J. Med. Res., 126: 417-427.
11. Kamatchi, C., H. Magesh, U. Sekhar and R. Vaidyanathan, 2009. Identification of clonal clusters of Klebsiella pneumoniae isolates from chennai by extended spectrum beta lactamase genotyping and antibiotic resistance phenotyping analysis. Am. J. Infect. Dis., 5: 74-82.
12. Karim, A., L. Poirel, S. Nagarajan and P. Nordmann, 2001. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcpl. FEMS Microbiol. Lett., 201: 237-241.
13. Karou, S.D., D.P. Ilboudo, W.M.C. Nadembega, Y. Ameyapoh and D. Ouermi et al., 2009. Antibiotic resistance in urinary tract bacteria in Ouagadougou. Pak. J. Biol. Sci., 12: 712-716.
14. Kingsley, J. and S. Verghese, 2008. Sequence analysis of bla CTX-M-28, an ESBL responsible for third-generation cephalosporin resistance in Enterobacteriaceae, for the first time in India. Indian J. Pathol. Microbiol., 51: 218-221.
15. Koneman, E.W., S.D. Allen, W.M. Janda, P.C. Schreckenberger and W.C. Winn, Jr., 1997. The Enterobacteriaceae. In: Color Atlas and Textbook of Diagnostic Microbiology, Baltimore, L.W.W. (Ed.). 5th Edn., JB Lippincott Co., Philadelphia, pp: 171-230.
16. Lee, J.M., S.J. Bae, J. J. Lee, K. Bae and S.H. Jeong et al., 2007. Four exact GES variants used for identification of GES-type ext ended-spectrum β-lactamases with different hydrolysis profiles and inhibitor-resistance patterns by pyrosequencing. Res. J. Microbiol., 2: 486-490.
17. Manikandan, S., S. Ganesapandian, M. Singh and A.K. Kumaraguru, 2011. Emerging of multi drug resistance human pathogens from urinary tract infections. Curr. Res. Bacteriol., 4: 9-15.
18. Mano, J.Y. and S. Yasanthi, 2008. Detection of extended spectrum P lactamases (ESBL) in the family of enterobacteriaceae at rural hospital. Indian J. Med. Res., 127: 671-671.
19. Mansouri, S., F. Norouzi, M. Moradi and N. Nakhee, 2011. Comparison of virulence factors among clinical isolates of Pseudomonas aeruginosa producing and non-producing extended spectrum P lactamases. Curr. Res. Bacteriol (In Press).
20. Mathai, D., P.R. Rhomberg, D.J. Biedenbach, R.N. Jones and India Antimicrobial Resistance Study Group, 2002. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: A survey of ten medical center laboratories. Diagn. Microbiol. Infect. Dis., 44: 367-377.
21. Menon, T., D. Bindu, C.P. Kumar, S. Nalini and M.A. Thirunarayan, 2006. Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Indian J. Med. Microbiol., 24: 117-120.
22. Mohammadi, M., E. Ghasemi, H. Mokhayeri, Y. Pournia and H. Boroun, 2010. Antimicrobial resistance patterns of E. coli detected from hospitalized urine culture samples. Asian J. Biol. Sci., 3: 195-201.
23. Narayanaswamy, A. and M. Mallika, 2011. Prevalence and susceptibility of extended spectrum beta-lactamases in urinary isolates of Escherichia coli in a tertiary care hospital, Chennai, South India. Internet J. Med. Update, 6: 39-43.
24. Patel, M.H., G.R. Trivedi, S.M. Patel and M.M. Yegad, 2010. Antibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to Amp-C β-lactamase in a tertiary care hospital. Urol. Ann., 2: 7-11.
25. Paterson, D.L. and R.A. Bonomo, 2005. Ext ended-spectrum beta-lactamases: A Clinical Update. Clin. Microbiol. Rev., 18: 657-686.
26. Pitout, J.D.D. and K.B. Laupland, 2008. Ext ended-spectrum β-lactamase-producing enterobacteriaceae: An emerging public-health concern. Lancet Infect. Dis., 8: 159-166.
27. Revathi, G. and S. Singh, 1997. Detection of expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J. Med. Microbiol., 15: 113-115.
28. Selvakumar, B.N. and R. Jasmine, 2007. Antibiotic susceptibility of ESBL-producing urinary isolates at a tertiary care hospital in Tiruchirappalli, South India. J. Med. Sci., 7: 443-446.
29. Shareef, S.A. and S.O. Yagoub, 2006. Incidence and isolation of bacteria associated with nosocomial Urinary Tract Infection (UTI) in sudanese women. Res. J. Microbiol., 1: 534-539.
30. Sibi, G., A.P. Devi, K. Fouzia and B.R. Patil, 2011. Prevalence, microbiologic profile of urinary tract infection and its treatment with trimethoprim in diabetic patients. Res. J. Microbiol., 6: 543-551.
31. Thomson, K.S., 2010. Extended-spectrum-β-lactamase, AmpC and carbapenemase issues. J. Clin. Microbiol., 48: 1019-1025.
32. Zinnat, S., I.M. Jahedul, A. Jesmin, A.H.M. Ishaque Chowdhury and M. Arifuzzaman, 2011. A study of antibacterial susceptibility and resistance pattern of E. coli causing urinary tract infection in Chittagong Bangladesh. Asian J. Biol. Sci (In Press).